Publikationen, an denen er mitarbeitet Antonio Gil Moreno (34)

2022

  1. Genomic Validation of Endometrial Cancer Patient-Derived Xenograft Models as a Preclinical Tool

    International Journal of Molecular Sciences, Vol. 23, Núm. 11

2021

  1. Modeling ANXA2-overexpressing circulating tumor cells homing and high throughput screening for metastasis impairment in endometrial carcinomas

    Biomedicine and Pharmacotherapy, Vol. 140

2020

  1. Evaluation of the intraoperative human papillomavirus test as a marker of early cure at 12 months after electrosurgical excision procedure in women with cervical high-grade squamous intraepithelial lesion: a prospective cohort study

    BJOG: An International Journal of Obstetrics and Gynaecology, Vol. 127, Núm. 1, pp. 99-105

  2. Intraoperative Human Papillomavirus Test Predicts 24-Month High-Grade Squamous Intraepithelial Lesion Recurrence Saving Costs: A Prospective Cohort Study

    Journal of Lower Genital Tract Disease, Vol. 24, Núm. 4, pp. 367-371

2019

  1. Addition of IMP3 to L1CAM for discrimination between low- and high-grade endometrial carcinomas: a European Network for Individualised Treatment of Endometrial Cancer collaboration study

    Human Pathology, Vol. 89, pp. 90-98

  2. Nerve-sparing versus non-nerve-sparing radical hysterectomy: Surgical and long-term oncological outcomes

    Oncotarget, Vol. 10, Núm. 44, pp. 4598-4608

2018

  1. Added Value of Estrogen Receptor, Progesterone Receptor, and L1 Cell Adhesion Molecule Expression to Histology-Based Endometrial Carcinoma Recurrence Prediction Models: An ENITEC Collaboration Study

    International Journal of Gynecological Cancer, Vol. 28, Núm. 3, pp. 514-523

  2. Patient-derived xenograft models for endometrial cancer research

    International Journal of Molecular Sciences, Vol. 19, Núm. 8

2017

  1. Metabolomic and Lipidomic Profiling Identifies the Role of the RNA Editing Pathway in Endometrial Carcinogenesis

    Scientific Reports, Vol. 7, Núm. 1

2016

  1. Exosome-like vesicles in uterine aspirates: A comparison of ultracentrifugation-based isolation protocols

    Journal of Translational Medicine, Vol. 14, Núm. 1

  2. L1CAM expression in endometrial carcinomas: An ENITEC collaboration study

    British Journal of Cancer, Vol. 115, Núm. 6, pp. 716-724

2012

  1. ETV5 cooperates with LPP as a sensor of extracellular signals and promotes EMT in endometrial carcinomas

    Oncogene, Vol. 31, Núm. 45, pp. 4778-4788

  2. Location of aortic node metastases in locally advanced cervical cancer

    Gynecologic Oncology, Vol. 125, Núm. 2, pp. 312-314

  3. Risk factors for progression or persistence of squamous intraepithelial lesions diagnosed during pregnancy

    Journal of Lower Genital Tract Disease, Vol. 16, Núm. 1, pp. 34-38

2011

  1. Pretherapeutic extraperitoneal laparoscopic staging of bulky or locally advanced cervical cancer

    Annals of Surgical Oncology, Vol. 18, Núm. 2, pp. 482-489

2010

  1. Total laparoscopic radical hysterectomy for cervical cancer in prolapsed uterus

    Archives of Gynecology and Obstetrics, Vol. 282, Núm. 1, pp. 63-67

2009

  1. Cell signaling in endometrial carcinoma: phosphorylated 4E-binding protein-1 expression in endometrial cancer correlates with aggressive tumors and prognosis

    Human Pathology, Vol. 40, Núm. 10, pp. 1418-1426

  2. Risk of recurrence during follow-up for optimally treated advanced epithelial ovarian cancer (EOC) with a low-level increase of serum CA-125 levels

    Annals of Oncology, Vol. 20, Núm. 2, pp. 294-297

2008

  1. Microinvasive carcinoma of the cervix. Management of a neoplasm with favorable prognosis

    Progresos en Obstetricia y Ginecologia, Vol. 51, Núm. 4, pp. 209-214

  2. Nadir CA-125 concentration in the normal range as an independent prognostic factor for optimally treated advanced epithelial ovarian cancer

    Annals of Oncology, Vol. 19, Núm. 2, pp. 327-331